A new vaccine against the common cold is showing promise in clinical trials.
Vaccine for Common Cold Shows Promise
Phase 2 trials show 78% efficacy against rhinovirus strains.
Phase 2 trials show 78% efficacy against rhinovirus strains.
A new vaccine against the common cold is showing promise in clinical trials.